EANS-Adhoc: LifeWatch to report on First Half Year and Second Quarter 2012 Results on August 22, 2012 (with document)

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

6-month report/LifeWatch AG

16.08.2012

+ Press release and Letter to Shareholders at 7:00 a.m. CEST (01:00
a.m.EDT);

+ Analyst and media conference held in Zurich at 10:00 a.m. CEST;

+ International Live Conference Call/Audio web cast at 10:00 a.m.
CEST;

Neuhausen am Rheinfall/Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) will report on its results for the first half year
and the second quarter 2012 on Wednesday, August 22, 2012 in Zurich.

You will find a PDF-version of this press release and a registration
form at the end of this message.

Press release and Letter to Shareholders at 7:00 a.m. CEST (1:00 a.m.
EDT):

LifeWatch will publish internationally the results for the first half
year and for the second quarter 2012 in a press release and letter to
shareholders at 7:00 a.m. CEST.

Analyst and media conference at 10:00 a.m. CEST:

LifeWatch will report on the first half year and second quarter 2012
results at an English-speaking analyst and media conference that will
take place in Zurich on

Wednesday, August 22, 2012; at 10:00 a.m. CEST
at the Zunfthaus zur Saffran, Limmatquai 54, 8001 Zurich/Switzerland

Please confirm your participation at the analyst and media conference
by returning the registration form by Monday, August 20, 2012.

International Live Conference Call / Audio web cast at 10:00 a.m.
CEST:

At 10:00 a.m. CEST, LifeWatch will also discuss the results in a live
conference call and audio web cast which will be accompanied by
presentation visuals. The conference call is also accessible as an
audio web cast in the Investor Relations section of the LifeWatch
Website www.irlifewatch.com where an archived version will remain
available for download.

The local dial-in numbers for the conference call are as follows:

+ 41 (0)91 610 56 00 (Europe)
+ 44 (0)203 059 58 62 (UK)
+ 1 (1)866 291 41 66 (USA - Toll-free)

All participants are requested to dial in at least ten minutes prior
to the call. No PIN is required to access the call.

About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on
SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare
technology and solution company, specializing in advanced telehealth
systems and wireless remote patient monitoring services. LifeWatch
services cater to individuals, ranging from high-risk and chronically
ill patients, to consumers of health and wellness products. LifeWatch
AG has operative subsidiaries in the United States, in Switzerland
and in Israel and is the parent company of LifeWatch Services Inc.,
and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a
leading US-based provider of cardiac monitoring services and home
sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch
Technologies Ltd., based in Israel, is a leading developer and
manufacturer of telemedicine products. The Company is planning to
introduce the LifeWatch V, an Android-based smartphone with medical
sensors and apps that uses a cloud-based service platform. For
additional information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is
available at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate,"
"continue,""anticipate," "intend,""expect" and similar expressions
are intended to identify forward-looking statements. LifeWatch AG has
based these forward-looking statements largely on current
expectations and projections about future events and financial trends
that it believes may affect the financial condition, results of
operations, business strategy, short term and long term business
operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and
assumptions. In light of these risks, uncertainties and assumptions,
the forward-looking events and circumstances described may not occur
and actual results could differ materially and adversely from those
anticipated or implied in the forward- looking statements. All
forward-looking statements are based only on data available to
LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any
forward-looking statements contained in this press release as a
result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/QBMtg1Sc
http://resources.euroadhoc.com/us/wgWZpOYn

Further inquiry note:
Sensus Investor and Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement euro adhoc
--------------------------------------------------------------------------------

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/QBMtg1Sc
http://resources.euroadhoc.com/us/wgWZpOYn

issuer: LifeWatch AG
Rundbuckstrasse 6
CH-8212 Neuhausen am Rheinfall
phone: +41 52 632 00 50
FAX: +41 52 632 00 51
mail: users@lifewatch.com
WWW: www.lifewatch.com
sector: Healthcare Providers
ISIN: CH0012815459
indexes: SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
SIX Swiss Exchange
language: English